期刊文献+

eIF-4E基因在非小细胞肺癌中的表达及与化疗敏感性的关系 被引量:1

The expression of EIF-4e gene in NSCLC and its correlation to chemotherapy sensitivity
在线阅读 下载PDF
导出
摘要 目的探讨e IF-4E基因在非小细胞肺癌(Non small cell lung cancer,NSCLC)表达及与化疗敏感性的关系。方法选用外科手术切除NSCLC组织60例以及癌旁正常组织30例作为对照,通过免疫组化检测癌组织以及正常肺组织中el F-4E的表达。NSCLC患者术后接受榄香烯顺铂治疗至少两周以上。比较el F-4E在癌组织以及正常肺组织中的表达、e IF-4E阴性表达患者和阳性表达患者的总生存期和化疗效果。结果 e IF-4E在NSCLC患者癌组织中的阳性表达率显著高于癌旁组织(P<0.01);e IF-4E阴性表达患者的OS较阳性患者明显延长,阳性表达患者的化疗完全缓解率亦显著低于e IF-4E阴性表达患者(P<0.01)。结论 e IF-4E可能成为NSCLC诊断的标志物,e IF-4E表达水平检测可用于NSCLC患者个体治疗方案的选择。 Objective To understand the expression of elF-4 e gene in non-small cell lung cancer (NSCLC) and its correlation to chemotherapy sensitivity. Method Sample tissues obtained by surgical excision from 60 cases of NSCLC and sample normal tissues adjacent to the carcinoma obtained from 30 cases were chosen for examination. The elF-4E expression in both type of tissues were then subjected to immunohistoehemical analysis. The patients were treated with elemene cisplatin postoperative chemotherapy for a period of more than 2 weeks. The expression of elF-4E, overall survival (OS) and curative effect were analyzed. Findings Positive expression rate of elF-4e in cancerous tissue was found significantly higher than that of the tissues adjacent to carcinoma (P 〈 0.01 ). OS in patients with elF-4e negatively expressed was found significantly longer than that of patients with elF-4e positively expressed, and complete remission rate in elF-4 e negatively expressed patients is significantly higher than that of elF-4e positively expressed patients( P 〈 0.01 ). Conclusion EIF-4e can serve as an indicator of lung cancer. The expression of eIF4E gene is correlated to tumorgenesis, invasion and metastasis of lung cancer. The elF-4e expression level detection can be used for the choice of individual treatment for NSCLC patients.
出处 《健康研究》 CAS 2015年第1期40-42,共3页 Health Research
基金 台州市黄岩区科技局资助项目(2012038)
关键词 eIF-4E基因 表达 NSCLC 化疗 敏感性 eIF-4e gene expression NSCLC chemotherapy sensitivity
  • 相关文献

参考文献7

二级参考文献52

  • 1王金万,孙燕,刘永煜,于起涛,张沂平,李凯,朱允中,周清华,侯梅,管忠震,李维廉,庄武,王东林,梁后杰,秦凤展,卢辉山,刘晓晴,孙红,张燕军,王杰军,罗素霞,杨瑞合,涂远荣,王秀问,宋恕平,周静敏,游丽芬,王竞,姚晨.重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J].中国肺癌杂志,2005,8(4):283-290. 被引量:627
  • 2于宝华,周晓燕.PI3K/Akt/mTOR的信号传导通路在恶性肿瘤中的研究进展[J].中华病理学杂志,2005,34(10):674-676. 被引量:20
  • 3对木章 大谷贵美 铃木卓等.宫颈癌术前Bleomycin Ifosfamide Nedaplatin疗法.日本妇产科杂志,2002,54:633-7.
  • 4Graft JR, Zimmer SG. Translational control and metastatic progression : Enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs[ J). Clin Exp Metasta- sis,2003 ;20(3) :265-73.
  • 5Peihong S, Perry F. Expression of nm23, MMP - 2, TIMP - 2 in breast neoplasm in Zhengzhou Center Hospital, China[J]. Ethiop Med J, 2007, 45 (1) : 79.
  • 6Gao N, Flynn DC, Zhang Z et al. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/ roTOR /p70S6K1 signaling in human ovarian cancer cells [J]. Am Physiol Cell Physiol, 2004, 287 (2) : 281.
  • 7Zhou X, Tan M, Stone Hawthorne Vet al. Activation of the Akt/mammalian target of rapamycin /4E - BP1 pathway by ErbB- 2 overexpression predicts tumor progression in breast cancer [J]. Clin Cancer Res, 2004, 10 (20) : 6779.
  • 8Zhang D, Brodt P. Type 1 insulin - like growth factor regulates MT1 - MMP synthesis and tumor invasion via PI 3 - kinase/ Akt signaling [J].Oncogene, 2003, 22 (7): 974.
  • 9Slupianek A, Nieborowska - Skorska M, Hoser Get al. Role if phosphatidylinositol 3 kinase - Akt pathway in nucleophos- min/anaplastic lymphoma kinase - mediated lymphomagenesis[J]. Cancer Res, 2001, 61 (5) : 2194.
  • 10Asnaghi L, Bruno P, Priulla M et al. mTOR: a protein kinase switching between life and death[J]. Pharmacol Res, 2004, 50 (6) - 545.

共引文献75

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部